Retension Pharmaceuticals
Falls Church
About Retension Pharmaceuticals
Retension Pharmaceuticals is a healthcare company.Heart disease remains the leading cause of death worldwide. Nearly 50% of adult Americans have elevated blood pressure.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $25.4M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2025)
- Website: retensionpharmaceuticals.comblank
- Phone: 1 (703) 624-2024
Canonical: https://fsome.com/organization/retension-pharmaceuticals-8221 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.